Application

13122383 · CD86 Antagonist Multi-Target Binding Proteins

Filed 2011-05-19 · Granted · Patent 9493564 (2016-11-15) The official file ↗The patent and its PDF ↗ · Art unit 1646 · Examiner Stephen L Rawlings Typical · CPC C07K 16/2827 · APTEVO THEAPEUTICS INC. · Cooley LLP / Emergent

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

17.6 mo

to disposition 65.9 mo

Statutes raised

112

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.